Literature DB >> 10709595

Gait pattern in patients with spastic diplegic cerebral palsy who underwent staged operations.

G Fabry1, X C Liu, G Molenaers.   

Abstract

Fifteen patients with spastic diplegic cerebral palsy (CP) were monitored for a mean length of 9.5 years after they underwent staged operations and were evaluated by gait analysis, including joint motion in the sagittal plane and the ground reaction force (GRF) in three dimensions. Results showed an increased hip flexion (132%) at midstance, a reduction of peak knee flexion (PKF) during swing (45%) accompanied by an augmented time of PKF during swing (50%), and an increased dorsiflexion of the ankle during swing (293%) as well as its time during the gait cycle, in comparison with normal values. Moreover, significant decreases of the vertical GRF at the terminal stance and the forward and backward GRF were present. Additionally, it was found that a bilateral popliteal angle < 20 degrees is acceptable in spastic CP. Staged operations gave unpredictable results in the correction of contracture of the hamstrings, the Achilles tendon, and the iliopsoas. The authors are convinced that gait analysis is useful in evaluating these patients and enhances the results of operative treatment, and they have since changed their approach toward multilevel simultaneous corrections.

Entities:  

Mesh:

Year:  1999        PMID: 10709595

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  3 in total

1.  Surgical correction of equinus deformity in children with cerebral palsy: a systematic review.

Authors:  Benjamin J Shore; Nathan White; H Kerr Graham
Journal:  J Child Orthop       Date:  2010-07-01       Impact factor: 1.548

2.  The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb.

Authors:  Guy Molenaers; Anja Van Campenhout; Katrien Fagard; Jos De Cat; Kaat Desloovere
Journal:  J Child Orthop       Date:  2010-03-18       Impact factor: 1.548

3.  [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].

Authors:  G Molenaers; K Desloovere; J De Cat
Journal:  Orthopade       Date:  2004-10       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.